Compare HDFC Pharma And Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.2
2.01
NAV
₹21.51
₹580.70
Fund Started
14 Sep 2023
04 Jun 1999
Fund Size
₹2611.33 Cr
₹4997.72 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
17.93%
13.61%
3 Year
-
23.38%
5 Year
-
16.20%
Equity
97.25%
97.16%
Cash
2.75%
2.78%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.96% |
Divi's Laboratories Ltd. | 7.16% |
Max Healthcare Institute Ltd. | 5.57% |
Lupin Ltd. | 5.26% |
Cipla Ltd. | 5.19% |
Aster DM Healthcare Ltd. | 5.05% |
Acutaas Chemicals Ltd. | 4.58% |
Alkem Laboratories Ltd. | 4.00% |
Anthem Biosciences Ltd. | 3.81% |
Ipca Laboratories Ltd. | 3.53% |
Sun Pharmaceutical Industries Ltd. | 11.18% |
Acutaas Chemicals Ltd. | 6.35% |
Divi's Laboratories Ltd. | 5.92% |
Apollo Hospitals Enterprise Ltd. | 5.21% |
Max Healthcare Institute Ltd. | 5.08% |
Aurobindo Pharma Ltd. | 4.17% |
Aster DM Healthcare Ltd. | 3.77% |
Laurus Labs Ltd. | 3.64% |
Cipla Ltd. | 3.52% |
Torrent Pharmaceuticals Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
14 Sep 2023
04 Jun 1999
